Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
francesco.delgiudice@uniroma1.it
Francesco Del Giudice
Assegnista di ricerca
Struttura:
DIPARTIMENTO MATERNO INFANTILE E SCIENZE UROLOGICHE
E-mail:
francesco.delgiudice@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
Surgical Technique and Perioperative Outcomes of the “Sapienza” Urology Residency Program’s Trocar Placement Configuration During Robotic-Assisted Radical Prostatectomy (RARP): A Retrospective, Single-Centre Observational Study Comparing Experienced Attendings vs. Post-Graduate Year I–III Residents as Bedside Assistants
CANCERS
2025
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis
TARGETED ONCOLOGY
2025
The Role of Butirprost® as an Adjuvant in Enhancing the Effect of Antibiotics in Patients Affected by Chronic Bacterial Prostatitis: A Randomized Prospective Trial
MEDICINA
2025
The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data
BJUI COMPASS
2025
Oncologic Outcomes of Endoscopic Management of Upper Tract Urothelial Carcinoma: A Systematic Review and Pooled Analysis from the EAU-YAU Urothelial Working Group
EUROPEAN UROLOGY FOCUS
2025
Obesity alters the fitness of peritumoral adipose tissue, exacerbating tumor invasiveness in renal cancer through the induction of ADAM12 and CYP1B1
MOLECULAR ONCOLOGY
2025
El impacto del enfoque multidisciplinar en la elección del tratamiento y los resultados del carcinoma urotelial: una revisión sistemática
ACTAS UROLÓGICAS ESPAÑOLAS
2025
Systematic review and meta-analysis of serum total testosterone and luteinizing hormone variations across hospitalized Covid-19 patients
SCIENTIFIC REPORTS
2024
How the Management of Biochemical Recurrence in Prostate Cancer Will Be Modified by the Concept of Anticipation and Incrementation of Therapy
CANCERS
2024
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol
BJU INTERNATIONAL
2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients
BIOMEDICINES
2024
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer
ONCOLOGY RESEARCH
2024
Partial nephrectomy in elderly patients: a systematic review and analysis of comparative outcomes
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2024
Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy
THE ONCOLOGIST
2024
Upper Tract Urothelial Cancer: Guideline of Guidelines
CANCERS
2024
Real-Life Comparative Analysis of Robotic-Assisted Versus Laparoscopic Radical Prostatectomy in a Single Centre Experience
CANCERS
2024
Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group Collaboration
EUROPEAN UROLOGY ONCOLOGY
2024
The Role of Mitomycin C in Intermediate-risk Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
EUROPEAN UROLOGY ONCOLOGY
2024
The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancer
WORLD JOURNAL OF UROLOGY
2024
Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer
CLINICAL GENITOURINARY CANCER
2024
1
2
3
4
5
6
7
8
9
10
11
12
…
next >
last »
ERC
LS4_12
Interessi di ricerca
Progetti di Ricerca
Magnetic Resonance Imaging-Targeted Biopsy for Primary Detection of Prostate Cancer: Magnetic Resonance Imaging (MRI) In-Bore versus MRI-Trans-rectal ultrasound (TRUS) Fusion Technique
Co-expression of Programmed Death Ligand 1 (PD-L1) and markers of Epithelial-Mesenchymal Transition (EMT) on Circulating Tumor Cells (CTCs): a possible immune escape mechanism in urothelial carcinomas of the urinary bladder.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma